Suchergebnisse - "Greig, Nigel H"

PubPharm (27)

1

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension : a randomized clinical trial

enthalten in: Brain : a journal of neurology | 2023

von Mitchell, J. | Lyons, H. | Walker, J. | +9

2

Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon

enthalten in: Scientific reports | 2019

von Li, Y. | Vaughan, K. | Tweedie, D. | +6

3

Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury

enthalten in: Neurobiology of disease | 2019

von Bader, M. | Li, Y. | Lecca, D. | +10

4

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease : A Secondary Analysis of the Exenatide-PD Trial

enthalten in: JAMA neurology | 2019

von Athauda, D. | Gulyani, S. | Karnati, H. | +9

CommentIn: JAMA Neurol. 2019 Apr 1;76(4):402-404. - PMID 30640380

5

A Pilot Study of Exenatide Actions in Alzheimer's Disease

enthalten in: Current Alzheimer research | 2019

von Mullins, R. | Mustapic, M. | Chia, C. | +9

6

Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease

enthalten in: Scientific reports | 2018

von Chen, S. | Yu, S. | Li, Y. | +8

ErratumIn: Sci Rep. 2018 Sep 12;8(1):13953. - PMID 30209317

7

Exenatide once weekly versus placebo in Parkinson's disease : a randomised, double-blind, placebo-controlled trial

enthalten in: Lancet (London, England) | 2017

von Athauda, D. | Maclagan, K. | Skene, S. | +15

CommentIn: Lancet. 2017 Oct 7;390(10103):1628-1630. - PMID 28781109

8

A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis : The Glucagon-Like Peptide-1 Receptor Pathway

enthalten in: Cell transplantation | 2017

von Kim, D. | Choi, H. | Wang, Y. | +3

9

Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration

enthalten in: Scientific reports | 2017

von Rachmany, L. | Tweedie, D. | Rubovitch, V. | +9

10

Insulin resistance and exendin-4 treatment for multiple system atrophy

enthalten in: Brain : a journal of neurology | 2017

von Bassil, F. | Canron, M. | Vital, A. | +7

CommentIn: Brain. 2017 May 1;140(5):1177-1179. - PMID 29050369